Indivior Pharmaceuticals Inc
INDV
Rank in Stocks
#3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Share Price
$34.01
Market Cap
$4.24B
Change (1 day)
4.81%
Change (1 year)
38.93%
Country
US
Trade Indivior Pharmaceuticals Inc (INDV)
Category
Healthcare
P/S ratio for Indivior Pharmaceuticals Inc (INDV)
P/S ratio as of October 2026 TTM: 3.20
According to Indivior Pharmaceuticals Inc latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.20. At the end of 2023 the company had a P/S ratio of 1.94.
P/S ratio history for Indivior Pharmaceuticals Inc from 2016 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 3.20 | 131.87% |
| 2024 | 1.38 | -28.93% |
| 2023 | 1.94 | -43.14% |
| 2022 | 3.42 | 5.76% |
| 2021 | 3.23 | 106.90% |
| 2020 | 1.56 | 235.34% |
| 2019 | 0.47 | -54.45% |
| 2018 | 1.02 | -70.40% |
| 2017 | 3.45 | 30.98% |
| 2016 | 2.64 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 120.57% |
IN
|
